Gelonghui, July 28? Qizheng Tibetan medicine released its semi-annual performance KuaiBao. During the reporting period, the company achieved a total operating income of 920 million yuan, an increase of 2.57% over the same period last year, of which the pharmaceutical business increased by 2.54% over the same period last year. The company realized an operating profit of 377 million yuan, an increase of 50.15% over the same period last year, and a net profit of 346 million yuan for shareholders of listed companies, an increase of 48.78% over the same period last year.
奇正藏药：2023年上半年净利润同比增长48.78%
Qizheng Tibetan Medicine: Net profit for the first half of 2023 increased by 48.78% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.